Comparative phenotypic characteristics of Staphylococcus aureus isolates from line and non-line associated septicaemia, CAPD peritonitis, bone/joint infections and healthy nasal carriers

Journal of Medical Microbiology

Volumn 47, Issue 3, 1998, Pages 265-274

  Al Wali, W I ^a   Elvin, S J ^b   Mason, C M ^a   Clark, A ^c   Tranter, H S ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL PERITONITIS; BACTERIOPHAGE TYPING; BACTERIUM CARRIER; BONE INFECTION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FIBRINOLYSIS; HEMOLYSIS; HUMAN; INFECTIOUS ARTHRITIS; MAJOR CLINICAL STUDY; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME; UNITED KINGDOM;

EID: 0031886991     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-3-265     Document Type: Article

References (72)

1. Sheagren JN. Staphylococcus aureus. The persistent pathogen. N Engl J Med 1984; 310: 1368-1373, 1437-1442.
2. Eykyn SJ, Grandsden WR, Phillips I. The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother 1990; 25 Suppl. C 41-58.
3. Gemmell CG. The Staphylococcus - new features 100 years after its discovery. J Infect 1982; 4: 5-15.
4. Elliot TSJ. Line-associated bacteraemias. CDR Rev 1993; 3: R91-R96.
5. Al-Wali W, Baillod R, Brumfin W, Hamilton-Miller JMT. Differing prognostic significance of reinfection and relapse in CAPD peritonitis. Nephrol Dial Transplant 1992; 7: 133-136.
6. Tranter HS, Brehm RD The detection and aetiological significance of staphylococcal enterotoxins. Rev Med Microbiol 1994; 5: 56-64.
7. Wieneke AA, Roberts D, Gilbert RJ. Staphylococcal food poisoning in the United Kingdom, 1969-90. Epidemiol Infect 1993; 110: 519-531.
8. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol 1995; 43: 318-327.
9. Crass BA, Bergdoll MS. Toxin involvement in toxic shock syndrome. J Infect Dis 1986; 153: 918-926.
10. Cone LA, Woodard DR, Byrd RG, Schulz K, Kopp SM, Schlievert PM. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 1992; 165: 638-643.
11. Humphreys H, Keane CT, Hone R et al. Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers. J Med Microbiol 1989; 28: 163-172.
12. Røder BL, Eriksen NHR, Nielsen LP, Slotsbjerg T, Rosdahl VT, Espersen F. No difference in enterotoxin production among Staphylococcus aureus strains isolated from blood compared with strains isolated from healthy carriers. J Med Microbiol 1995; 42: 43-47.
13. Hasegawa N, Kondo I. Isolation and virulence of a caseinaseand bound coagulase-deficient mutant of Staphylococcus aureus BB. J Infect Dis 1984; 149: 538-543.
14. Todd JK, Franco-Buff A, Lawellin DW, Vasil ML. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun 1984; 45: 339-344.
15. Rollof J, Hedstrom A, Nilsson-Ehle P. Lipolytic activity of Staphylococcus aureus strains from disseminated and localized infections. Acta Path Microbiol Immunol Scand Sect B 1987; 95: 109-133.
16. Hedstrom SA, Nilsson-Ehle P. Trioleoylglycerol lipolysis by Staphylococcus aureus strains from recurrent furunculosis, pyomyositis, impetigo and osteomyelitis. Acta Path Microbiol Immunol Scand Sect B Microbiol 1983; 91: 169-173.
17. Chernevskaia OM, Zavarukhina MA, Ermoling GB. Variability of the pathogenicity traits of populations of staphylococci in a surgical hospital. Zh Mikrobiol Epidemiol Immunobiol 1985; 7: 29-32.
18. Roberts JI, Gaston MA. Protein A and coagulase expression in epidemic and non-epidemic Staphylococcus aureus. J Clin Pathol 1987; 40: 837-840.
19. Freeman R, Hudson SJ, Burdess D. Crystal violet reactions of fresh clinical isolates of Staphylococcus aureus from two British hospitals. Epidemiol Infect 1990; 105: 493-500.
20. Lehn N, Schaller E, Wagner H, Kronke M. Frequency of toxic shock syndrome toxin and enterotoxin producing clinical isolates of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1995; 14: 43-46.
21. Adesiyun AA, Lenz W, Schaal KP. Phage susceptibility, enterotoxigenicity and antibiograms of Staphylococcus aureus strains isolated from human wounds and diarrhoea. Int J Med Microbiol Virol Parasitol Infect Dis 1992; 277: 250-259.
22. Takesue Y, Yokoyama T, Kodama T et al. A study on postoperative enteritis caused by methicillin-resistant Staphylococcus aureus. Surg Today 1993; 23: 4-8.
23. Kimura A, Iqarashi H, Ushioda H, Okuzumi T. Epidemiological study of Staphylococcus aureus isolated from the Japanese National University and Medical College Hospitals with coagulase typing and production of enterotoxins and toxic shock syndrome toxin-1. Kansenshogaku Zasshi 1992; 66: 1543-1549.
24. Jordens JZ, Duckworth GJ, Williams RJ. Production of 'virulence factors' by 'epidemic' methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol 1989; 30: 245-252.
25. Naidu S, Rao PN, Rajyalakshmi K, Naidu AS. Incidence of enterotoxin producing Staphylococcus aureus among pyogenic skin infections. J Hyg Epidemiol Microbiol Immunol 1989; 33: 277-282.
26. Christensson B, Heström SÅ. Biochemical and biological properties of Staphylococcus aureus septicaemia strains in relation to clinical characteristics. Scand J Infect Dis 1986; 18: 297-303.
27. Reynolds D, Tranter HS, Sage R, Hambleton P. Novel method for purification of staphylococcal enterotoxin A. Appl Environ Microbiol 1988; 54: 1761-1765.
28. Modi NK, Rose SA, Tranter HS. The effects of irradiation and temperature on the immunological activity of staphylococcal enterotoxin A. Int J Food Microbiol 1990; 11: 85-92.
29. Larsson A, Wejaker PE, Sjoquist. Chicken anti-protein A for the detection and capturing of protein A from Staphylococcus aureus in the presence or absence of mammalian IgG. Hybridoma 1992; 11: 239-243.
30. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
31. Mollby R. Isolation and properties of membrane damaging toxins. In: Easmon CSF, Adlam C (eds) Staphylococci and staphylococcal infections, vol 2. The organism in vivo and in vitro. London Academic Press 1983: 619-669.
32. 2-enhanced hemolytic activity of Staphylococcus aureus associated with toxic shock syndrome: inhibition by agar. J Infect Dis 1986; 154: 186-188.
33. Lawrence RC, Fryer TF, Reiter B. Rapid method for the quantitative estimation of microbiol lipases. Nature 1967; 25: 1264-1265.
34. Lundbeck H, Tirunarayanan MO. Investigation on the enzymes and toxins of staphylococci. Study of the 'egg yolk reaction' using an agar plate assay method. Acta Pathol Microbiol Scand 1966; 68: 123-134.
35. Rollof J, Hedstrom SA, Nilsson-Ehle P. The Tween 80 reaction does not correlate to triglyceride lipase production of Staphylococcus aureus. APMIS 1988; 96: 732-734.
36. Collee JG, Duguid JP, Fraser AG, Marmion BP. Mackie and McCartney's Practical medical microbiology 3rd edn, vol 2. Tests for identification of bacteria. Edinburgh, Churchill Livingstone. 1989: 141-160.
37. Devriese LA, van de Kerckhove. A comparison of methods used for testing staphylokinase (fibrinolysin) production in Staphylococcus strains. Antonie van Leuwenhoek 1980; 46: 457-465.
38. Blair JE, Williams REO. Phage typing of staphylococci. Bull Wld Hlth Organ 1961; 24: 771-784.
39. Parker MT. The significance of phage-typing patterns in Staphylococcus aureus. In: Easmon CSF, Adlam C (eds) Staphylococci and staphylococcal infections, vol 1. Clinical and epidemiological aspects. London, Academic Press. 1983: 33-62.
40. Altman GA. Comparing groups - categorical data. Comparing groups - continuous data. In: Altman GA. Practical statistics for medical research. London, Chapman and Hall. 1995: 179-223, 229-272.
41. Peavy DL, Adler WH, Smith RT. The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol 1970: 105: 1453-1458.
42. Fleming SD, Iandolo JJ, Chapes SK. Murine macrophage activation by staphylococcal enterotoxins. Infect Immun 1991; 59: 4049-4055.
43. Fast DJ, Schlivert PM, Nelson RD. Nonpurulent response to toxic shock syndrome toxin-1 producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J Immunol 1988; 140: 949-953.
44. Koyama A, Kobayashi M, Yamaguchi N et al. Glomerulone-phritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int 1995; 47: 207-216.
45. De Boer ML, Chow AW. Toxic shock syndrome toxin-1 producing Staphylococcus aureus isolates contain the Staphylococcus enterotoxin B. J Infect Dis 1994; 170: 818-827.
46. Lee VTP, Chang AH, Chow AW. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS) and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis 1992; 116: 911-915.
47. Bergdoll MS. Enterotoxins. In: Easmon CSF, Adlam C (eds) Staphylococci and staphylococcal infections, vol 2. The organism in vivo and in vitro. London, Academic Press. 1983; 559-598.
48. Nagaki M, Muto Y, Ohnish H et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the super-antigen staphylococcal enterotoxin B. Gastroenterology 1994; 106: 450-458.
49. Tokura Y, Yagi J, O'Malley M et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhan cells on class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell activating cytokines. J Invest Dermatol 1994; 102: 31-38.
50. Nagaki M, Muto Y, Ohnishi H et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 1994; 106: 450-458.
51. Sugiyama H, McKissic EM, Bergdoll MS Heller B. Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin. J Infect Dis 1964; 114: 111-118.
52. Naidu S, Rao PN, Rajyalakshimi K, Naidu AS. Incidence of enterotoxin producing Staphylococcus aureus among pyogenic skin infections. J Hyg Epidemiol Microbiol Immunol 1989; 33: 277-282.
53. Telford DR, Morris JA, Hughes P et al. The nasopharyngeal bacterial flora in sudden infant death syndrome. J Infect 1989; 18: 125-130.
54. Koyama A, Kobayaski M, Yamaguchi N et al. Glomerulone-phritis association with MRSA infection: a possible role of bacterial superantigen. Kidney Int 1995; 47: 207-216.
55. Arvidson S. Genetic loci controlling the expression of virulence genes in Staphylococcus aureus. Eighth International Symposium on Staphylococci and Staphylococcal Infections, France 1996 (Abstract).
56. Betley MJ, Borst EW, Regassa LB. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. In: Fleisher B (ed) Biological significance of superantigens, vol 55. Clinical immunology. Basel, Karger. 1992: 1-35.
57. Christensson B, Hadstrom SA, Kronvall G. Antibody response to alpha- and beta-hemolysin from Staphylococcus aureus in patients with staphylococcal infections and in normals. Acta Pathol Microbiol Immunol Scand B 1983; 91: 351-356.
58. Rogolsky M. Nonenteric toxins of Staphylococcus aureus. Microbiol Rev 1979; 43 320-360.
59. Weigershausen B. On the pharmacology of staphylococcal toxin (Wood 46). The effect of staphylococcal toxin on the isolated heart, auricles and vessels of various species. Act Biol Med Ger 1962; 9; 517.
60. Takeuehi S, Suto T. Behaviours of a vigorous protease-producing strain of Staphylococcus aureus in the skin tissue of mice. Jpn J Microbiol 1976; 20: 155-162.
61. Kapral FA, O'Brien AD, Ruff PD, Drugan WJ. Inhibition of water absorption in the intestine by Staphylococcus aureus delta-toxin. Infect Immun 1976; 13: 140-145.
62. Prevost G, Couppie P, Prevost P et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Micribiol 1995: 42: 237-245.
63. Rollof J, Braconier JH, Soderstrom C, Nilson-Ehle P. Interference of Staphylococcus aureus lipase with human granulocyte function. Eur J Clin Microbiol Infect Dis 1988; 7: 505-510.
64. Porwiit-Bobr Z. Modulation of lymphocytes and immunoglobulins by serine proteinase of Staphylococcus aureus. Med Dosw Mikrobiol 1993; 45: 37-40.
65. Baran K, Midzobrodzki J, Porwit-Bobr Z. Preliminary estimation of chemoattractant activity of staphylococcal serine proteinase in vitro. Chemoattractant activity of staphylococcal serine proteinase. Antonie van Leuwenhoek 1988; 54: 85-87.
66. Le HV, Seeling GF, Syto R et al. Selective proteolytic cleavage of recombinant human interleukin-4. Evidence for a critical role of the C-terminus. Biochemistry 1991; 30: 9576-9582.
67. Arakawa T, Horan TP, McGinley M, Rohde MF. Effect of amino-terminal processing by Staphylococcus aureus V-8 protease on activity and structure of recombinant human interferon-gamma. J Interferon Res 1990; 10: 321-329.
68. Hasegawa N, Kondo I. Isolation and virulence of caseinaseand bound coagulase-deficient mutant of Staphylococcus aureus BB. J Infect Dis 1984; 149: 538-843.
69. Todd JK, Frano-Buff A, Lawellin DW, Vasil ML. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun 1984; 45: 339-344.
70. Sanford BA, Thomas VL, Ramsay MA, Jones TO. Characterization of clinical strains of Staphylococcus aureus associated with pneumonia. J Clin Microbiol 1986; 24: 131-136.
71. Arai K, Muto T, Yamasa M, Yokota S. Effect of the passage and storage of strains and inoculum size on the change of zone pattern types and sizes produced by protease of MRSA. Jpn J Assoc Infect Dis 1993; 67: 629-634.
72. Hudson SJ, Freeman R, Burdess D, Cookson BD. Crystal violet reactions of Staphylococcus aureus strains colonizing infants in the first six weeks. Epidemiol Infect 1993; 110; 79-86.